Register Now - Beyond Recruitment: The Future of Patient Site Engagement in Oncology Clinical Trials
|Articles|January 1, 2007

Applied Clinical Trials

  • Applied Clinical Trials-01-01-2007
  • Volume 0
  • Issue 0

eShowcase: CogState DataPoint

Web-based system puts sponsors running brain function clinical trials in the know

Web-based system puts sponsors running brain function clinical trials in the know

CogState Ltd. (Melbourne, Australia) has released the first real-time cognitive data monitoring system, called DataPoint, which allows pharmaceutical companies to access, monitor, and review data from global, multicenter trials at a central and secure Web-based location. The tool is targeted toward trials where cognitive function is the primary endpoint and represents a significant technological departure from paper and pencil cognitive brain function measurements.

One of the main benefits, says CogState, is that DataPoint enables clinical researchers to respond much more quickly to data coming out of clinical trials. For example, DataPoint delivers cleaned datasets and cognitive reports to pharmaceutical clients within hours of study completion, compared to the usual weeks. DataPoint also functions as the main point of contact between sponsors and CogState, and all study-specific software and manuals required to upload data and run a trial are accessible from one central source.

CogState Ltd., +61-3-9664-1300, www.cogstate.com

Articles in this issue

almost 20 years ago

eShowcase: TCN e-Systems

almost 20 years ago

Beyond Blockbusters

almost 20 years ago

Meet the EAB: Aaron F. Bartlone

almost 20 years ago

New Year Brings New Opportunities

almost 20 years ago

ACT European Summit Report

almost 20 years ago

Reverse Auctions: Crusade or Curse?

Related to this article

Closing the Community Access Gap: Q&A with Kent Thoelke, Paradigm Health
In this Q&A, Kent Thoelke, CEO of Paradigm Health, discusses why participation gaps in community and rural settings come down to both patient cost barriers and site infrastructure, how legacy workflows weigh on community clinics, and what policy and technology changes it would take to make clinical research a real care option for more patients.
© Grispb - © Grispb - stock.adobe.com
Mistral and OpenAI produced identical overall eligibility labels across 200 synthetic patient-study assessments, with criterion-level disagreements concentrated in inclusion criteria where models switch between “Uncertain” and “Not included” when records lack sufficient evidence, so model choice should be driven by deployment architecture, control, and cost rather than assumed interchangeability.
The Human Side of Clinical Trials: Before Burden Becomes Risk, Capturing Friction in Real Time
In Episode 4 of The Human Side of Clinical Trials, host Brian S. McGowan, PhD, FACEHP, chief learning officer and co-founder of ArcheMedX, Inc., speaks with Jason Riis, PhD, CEO and chief behavioral scientist at Behavioralize, about how capturing friction closer to the moment it happens can reveal unclear instructions, technology friction, and workarounds that retrospective surveys and debriefs tend to miss.